
|Videos|July 24, 2018
MDS/AML Overlap and Novel Therapies with Dr. Naval Daver
Author(s)Aplastic Anemia, MDS International Foundation
Dr. Naval Daver from MD Anderson Cancer Center talks about the relationship between MDS and AML and discusses new and novel treatments for both diseases.
Advertisement
Dr. Naval Daver from MD Anderson Cancer Center talks about the relationship between MDS and AML and discusses new and novel treatments for both diseases.
Some of the questions answered include:
How are MDS and AML connected? (define each briefly and discuss connection)
What are some new and novel therapies to treating higher risk MDS and AML?
What might these mean for patients? What do you think the future holds for treating AML secondary to MDS?
This video was recorded at the Aplastic Anemia and MDS International Foundation's Scientific Symposium in March, 2018.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
FDA Withdraws Krazati/Erbitux Approval in KRAS G12C-Mutated Colorectal Cancer
3
FDA Grants Accelerated Approval to Hyrnuo for Certain Patients With HER2-Mutated NSCLC
4
The Oncology Nurse Who Got Me Through 2 Years of Cancer Treatment
5




